INS and Hyperglycemia: Accordingly, injection of purified human α-subunit increases blood glucose levels in mice [32], and transgenic mice secreting soluble α-subunit into the plasma have chronic hyperglycaemia [33], presumably due to sequestering of plasma insulin after binding to the sIR [30].